Drugs / Signature Cord Prime
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05234489 Comparator | Feb 2022 → Jun 2023 | osteoarthritis, knee | Thomas Klootwyk, MD | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Signature Cord Prime | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05234489 ↗ |
| Known as | SIG001 | “a specific type of umbilical cord tissue-derived product (SIG001)” NCT05234489 ↗ |
| Route | Other | “intra-articular injection of SIG001” NCT05234489 ↗ |